Showing 1 - 20 results of 21 for search 'Hermiston, T', query time: 0.06s
Refine Results
-
1
OvAd1, a novel, potent, and selective chimeric oncolytic virus developed for ovarian cancer by 3D-directed evolution by Kuhn, I, Bauzon, M, Green, N, Seymour, L, Fisher, K, Hermiston, T
Published 2017Journal article -
2
Mature B‐cell lymphomas in adolescents and young adults by Nader Kim El‐Mallawany, Lisa Giulino‐Roth, John M. Burke, Michelle Hermiston, Carl E. Allen
Published 2023-11-01
Article -
3
-
4
CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition. by Lauren K Meyer, Cristina Delgado-Martin, Shannon L Maude, Kevin M Shannon, David T Teachey, Michelle L Hermiston
Published 2019-01-01
Article -
5
-
6
-
7
-
8
Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus by Illingworth, S, Di, Y, Bauzon, M, Lei, J, Duffy, M, Alvis, S, Champion, B, Lieber, A, Hermiston, T, Seymour, L, Beadle, J, Fisher, K
Published 2017Journal article -
9
Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase. by Anthony J O'Donoghue, Ye Jin, Giselle M Knudsen, Natascha C Perera, Dieter E Jenne, John E Murphy, Charles S Craik, Terry W Hermiston
Published 2013-01-01
Article -
10
Directed evolution generates a novel oncolytic virus for the treatment of colon cancer by Kuhn, I, Harden, P, Bauzon, M, Chartier, C, Nye, J, Thorne, S, Reid, T, Ni, S, Lieber, A, Fisher, K, Seymour, L, Rubanyi, G, Harkins, R, Hermiston, T
Published 2008Journal article -
11
Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer Biomarkers by Gloria I. Perez, Matthew P. Bernard, Daniel Vocelle, Ahmed A. Zarea, Najla A. Saleh, Matthew A. Gagea, Doug Schneider, Maxine Bauzon, Terry Hermiston, Masamitsu Kanada
Published 2023-03-01
Article -
12
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus by Sam Illingworth, Ying Di, Maxine Bauzon, Janet Lei, Margaret R. Duffy, Simon Alvis, Brian Champion, André Lieber, Terry Hermiston, Len W. Seymour, John Beadle, Kerry Fisher
Published 2017-06-01
Article -
13
Pre‐and post‐HSCT use of TKI therapy for fusion‐driven B‐ALL: A case series of five pediatric, adolescent and young adult patients by Savannah S. Shumock, William C. Temple, Amanda Marinoff, Kathryn Aaronson, Erica Southworth, Simayijiang Xirenayi, Alex G. Lee, Stanley G. Leung, E. Alejandro Sweet‐Cordero, Michelle Hermiston, Christine Higham, Elliot Stieglitz
Published 2023-12-01
Article -
14
Directed evolution generates a novel oncolytic virus for the treatment of colon cancer. by Irene Kuhn, Paul Harden, Maxine Bauzon, Cecile Chartier, Julie Nye, Steve Thorne, Tony Reid, Shaoheng Ni, Andre Lieber, Kerry Fisher, Len Seymour, Gabor M Rubanyi, Richard N Harkins, Terry W Hermiston
Published 2008-06-01
Article -
15
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators by Dyer, A, Di, Y, Calderon, H, Illingworth, S, Kueberuwa, G, Tedcastle, A, Jakeman, P, Chia, S, Brown, A, Silva, M, Barlow, D, Beadle, J, Hermiston, T, Ferguson, D, Champion, B, Fisher, K, Seymour, L
Published 2016Journal article -
16
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators by Arthur Dyer, Ying Di, Hugo Calderon, Sam Illingworth, Gray Kueberuwa, Alison Tedcastle, Phil Jakeman, Suet Lin Chia, Alice Brown, Michael A. Silva, David Barlow, John Beadle, Terry Hermiston, David J.P. Ferguson, Brian Champion, Kerry D. Fisher, Leonard W. Seymour
Published 2017-03-01
Article -
17
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies by Elliot Stieglitz, Aaron C Logan, Emilio Ramos, William C Temple, Matthew A Nix, Akul Naik, Adila Izgutdina, Benjamin J Huang, Gianina Wicaksono, Paul Phojanakong, Juan Antonio Camara Serrano, Elizabeth P Young, Fernando Salangsang, Veronica Steri, Simayijiang Xirenayi, Michelle Hermiston, Arun P Wiita
Published 2023-11-01
Article -
18
Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model by Yaya Chu, Sanghoon Lee, Tishi Shah, Changhong Yin, Matthew Barth, Rodney R. Miles, Janet Ayello, Erin Morris, Lauren Harrison, Carmella Van de Ven, Paul Galardy, Stanton C. Goldman, Megan S. Lim, Michelle Hermiston, Linda M. McAllister-Lucas, Lisa Giulino-Roth, Sherrie L. Perkins, Mitchell S. Cairo
Published 2019-01-01
Article -
19
S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II B... by V. Minard-Colin, J. Buechner, F. Locatelli, B. Gonzalez Martinez, B. J. Vormoor, S. Cooper, J. Krueger, S. Napolitano, A. Attarbaschi, A. Baruchel, S. Ghorashian, M. L. Hermiston, H. Hiramatsu, M. Ifversen, S. John, S. L. Khaw, T. A. O’Brien, C. L. Phillips, C. Diaz de Heredia, D. Tomizawa, K. Vettenranta, A. S. Wayne, S. Newsome, R. Awasthi, S. Redondo, A. Masood, S. L. Maude, B. Burkhardt
Published 2022-06-01
Article -
20
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world pattern... by Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather Stefanski, Julie-An Talano, Amy Moskop, Susanne Baumeister, Michael R. Verneris, Gary Douglas Myers, Nicole A. Karras, Stacy Cooper, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy Keating, Vanessa Fabrizio, Vasant Chinnabhandar, Michael Kunicki, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Published 2023-11-01
Article